Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3815734 | 0.91 | MAPT (0.45) | NPSR1MAPTALDH1A1L3MBTL1LMNA | |
| SCHEMBL9613268 | 0.91 | MAPT (0.41) | NPSR1MAPTALDH1A1L3MBTL1LMNA | |
| SCHEMBL7205756 | 0.90 | MAPT (0.47) | NPSR1MAPTALDH1A1L3MBTL1LMNA | |
| SCHEMBL12049719 | 0.86 | CYP3A4 (0.38) | NPSR1MAPTALDH1A1L3MBTL1 | |
| SCHEMBL12380772 | 0.86 | KMT2A (0.33) | NPSR1MAPTALDH1A1 | |
| SCHEMBL5640425 | 0.80 | KDM4E (0.39) | NPSR1MAPTALDH1A1L3MBTL1 | |
| SCHEMBL208348 | 0.79 | MGAM (0.37) | NPSR1ALDH1A1LMNA | |
| SCHEMBL3239495 | 0.73 | — | — | |
| SCHEMBL1189812 | 0.73 | — | — | |
| SCHEMBL9781658 | 0.72 | CYP4F2 (0.36) | NPSR1MAPTALDH1A1L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117045653-A | Diseases and treatments associated with toxic aldehydes | 奥尔德拉医疗公司 | 2023-11-14 | — | — | CN | disclosed |
| CN-111135171-B | Diseases and treatments associated with toxic aldehydes | 奥尔德拉医疗公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-114085236-A | Aldehyde conjugates and uses thereof | 奥尔德拉医疗公司 | 2022-02-25 | — | — | CN | disclosed |
| CN-111135171-A | Diseases and treatments associated with toxic aldehydes | 奥尔德拉医疗公司 | 2020-05-12 | — | — | CN | disclosed |
| CN-105120866-B | Diseases and treatments associated with toxic aldehydes | 奥尔德拉医疗公司 | 2020-02-14 | — | — | CN | disclosed |
| EP-0705834-A1 | Quinoxaline-2,3-diones with an azaheterocyclic fused ring | CIBA-GEIGY AG (CH) | 1996-04-10 | — | — | EP | disclosed |
| US-4911750-A | Mixture of a 1,2,4-triazole and phosphorus compound | BAYER AKTIENGESELLSCHAFT (DE) | 1990-03-27 | — | — | US | disclosed |
| US-4570014-A | Cycloalkanecarboxylic acid compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1986-02-11 | — | — | US | disclosed |
| US-4554017-A | Method and compositions for regulating plant growth using cycloalkane-carboxylic acid compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1985-11-19 | — | — | US | disclosed |
| US-4452625-A | 1,2,4-TETRAZOLE COMPOUND WITH A CYCLOPROPANE CARBOXY COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 1984-06-05 | — | — | US | disclosed |